2019
DOI: 10.1093/europace/euz140
|View full text |Cite
|
Sign up to set email alerts
|

Effect of remote monitoring on patient-reported outcomes in European heart failure patients with an implantable cardioverter-defibrillator: primary results of the REMOTE-CIED randomized trial

Abstract: Aims The European REMOTE-CIED study is the first randomized trial primarily designed to evaluate the effect of remote patient monitoring (RPM) on patient-reported outcomes in the first 2 years after implantation of an implantable cardioverter-defibrillator (ICD). Methods and results The sample consisted of 595 European heart failure patients implanted with an ICD compatible with the Boston Scientific LATITUDE® RPM system. Pat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
26
0
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 30 publications
(31 citation statements)
references
References 23 publications
0
26
0
2
Order By: Relevance
“…In line with these neutral results, a sub-analysis of the ECOST trial failed to demonstrate a benefit in QoL in the RPM group [32]. The just recently published REMOTE-CIED trial specifically designed to assess health status in a heart-failure cohort confirms the majority of former studies not identifying any specific benefit of RPM surveillance on patient-reported outcomes [6].…”
Section: Comparison To Previous Studiesmentioning
confidence: 70%
See 1 more Smart Citation
“…In line with these neutral results, a sub-analysis of the ECOST trial failed to demonstrate a benefit in QoL in the RPM group [32]. The just recently published REMOTE-CIED trial specifically designed to assess health status in a heart-failure cohort confirms the majority of former studies not identifying any specific benefit of RPM surveillance on patient-reported outcomes [6].…”
Section: Comparison To Previous Studiesmentioning
confidence: 70%
“…However, the majority of recent large randomized-controlled trials has failed to provide consistent evidence for the superiority on hard clinical endpoints, i.e., mortality [3][4][5]. Additional potential effects of RPM, such as improvement of patientreported outcomes, are not well investigated [6]. Therefore, we investigated the effect of RPM in addition to standard in-office ICD follow-up on patient-reported outcomes compared to patients receiving standard in-office ICD follow-up only.…”
Section: Introductionmentioning
confidence: 99%
“…However, similar to previous studies, a subgroup of our sample (16%‐19%) did not wish to continue RPM in the future, reported a preference toward in‐clinic follow‐up (19%), or reported to have no preference (38%). Furthermore, 15% of all the patients who refused study participation were not willing to be randomized to RPM follow‐up (15%) . Motives to prefer in‐clinic follow‐up were a need for personal contact with physicians, short travel distance to the hospital, and negative experiences with the RPM system.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, 15% of all the patients who refused study participation were not willing to be randomized to RPM follow-up (15%). 37 Motives to prefer in-clinic follow-up were a need for personal contact with physicians, short travel distance to the hospital, and negative experiences with the RPM system. Patients with a preference for in-clinic follow-up were more likely to be less educated, unemployed, to suffer from COPD, and to be equipped with an older LATITUDE model.…”
Section: Discussionmentioning
confidence: 99%
“…The EVOLVO (Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators) study demonstrated a reduction of 35% in urgent admissions and 21% in urgent office-based visits for worsening HF in the RPM arm, even though this study was not powered to demonstrate clinical benefit [ 18 ]. Further, the REMOTE-CIED ( Remote patient management for Cardiac Implantable Electronic Devices) trial showed that patient-reported health status and ICD acceptance did not differ between patients on RPM and patients receiving in-clinic check-ups alone in the first 2 years after ICD implantation [ 19 ].…”
Section: Introductionmentioning
confidence: 99%